Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2003
11/26/2003EP1025096B1 Substituted chroman derivatives
11/26/2003EP1025095B1 Substituted chroman derivatives
11/26/2003EP0927177B1 Novel benzothiophene derivatives, their preparation and use as urokinase inhibitors
11/26/2003EP0888123B1 Antagonism of endothelin actions
11/26/2003EP0765326B1 Benzoylecgonine, ecgonine and ecgonidine derivatives
11/26/2003EP0757038B1 Benzamide compound and medicinal use thereof
11/26/2003CN1458979A Modulating multiple lineage kinase proteins
11/26/2003CN1458930A Tartrate salts of thiazolidinedione derivative
11/26/2003CN1458929A Chemokine receptor binding heterocyclic compounds
11/26/2003CN1458928A N-substituted benzothiophenesulfonamide derivatives
11/26/2003CN1458926A Nitric oxide donors based on metallic centres
11/26/2003CN1458846A Synthetic erythropoiesis stimulating protein
11/26/2003CN1458845A Pharmaceutical composition comprising condensed indole compound
11/26/2003CN1458843A Aotomatic controlling nurve regulator and its health drinks and foods
11/26/2003CN1458840A Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
11/26/2003CN1458158A Biphosphonate
11/26/2003CN1458149A Use of phenolic dauricine in preparing myocardial ischemia medicine
11/26/2003CN1457875A Preparing medicinal liquid for treating piles from pare natural hawthorn fruit kernel
11/26/2003CN1457863A Pill for treating apoplexy and hemiparalysis
11/26/2003CN1457862A Paste for treating cardio-cerebral vascular diseases, hepatitis and ruducing blood fat and blood pressure
11/26/2003CN1457860A Chinese medicine for treating piles
11/26/2003CN1457857A Prepared licorice granular powder
11/26/2003CN1457853A Chinese medicine composition for treating ischemic apoplexy and its preparing method
11/26/2003CN1457841A Composition for curing angina pectoris
11/26/2003CN1457835A Draqon's blood dripping pill for removing blood stasis and killing pain, arresting bleeding and promoting granulation and its preparing method
11/26/2003CN1457832A Medicine for curing cardiovascular and cerebrovascular diseases
11/26/2003CN1457831A Dynamic medicine for channels and collaterals and blood vessel
11/26/2003CN1457827A Capsule for curing paralysis
11/26/2003CN1457811A Chinese medicine preparation for curing hemorrhoidal bleeding
11/26/2003CN1457795A Pueraria root flavone self-microemulsified soft capsule and its preparing method
11/26/2003CN1457785A Doxazosin mesilate slow releasing preparation
11/26/2003CN1457784A Method for producing xinnaoning injectin containing chuanxiong rhizome and red sage root extract
11/26/2003CN1457776A Self emulsified soft capsule of ginkgo leaf extract and its preparing method
11/26/2003CN1457773A Biguanide vanadium complex granular powder and/or capsule for curing diabetes and its use
11/26/2003CN1128801C Triazolo (4,5-D) pyrimidine compounds
11/26/2003CN1128788C Benzyl(idene)-lactam derivatives, their prepn. and their use as selective(ant) agonists of 5-HT 1A and/or 5-HT 1D receptors
11/26/2003CN1128636C Pharmaceutical angiostatic dipeptide compositions and method of use thereof
11/26/2003CN1128616C Use of water-free lactose in producing solid mixtures containing nitroglycerine
11/26/2003CN1128613C Combination of progresterone antagonists and anti-oestrogens with partial agonistic action for use in hormone-replacement therapy for perio- and post menopansal woman
11/25/2003US6653508 Use treating various medical conditions, including pain
11/25/2003US6653493 Lipoxin compounds and their use in treating cell proliferative disorders
11/25/2003US6653448 Wnt-7B-like polypeptides and nucleic acids encoding same
11/25/2003US6653446 Nucleotide sequences which code enzymatic polypeptide for use in treatment of gout, kidney, blood and preferential genetic disorders
11/25/2003US6653382 Ethylene-unsaturated carboxylic acid copolymer; ionomers; resilience, melt processability
11/25/2003US6653347 For therapy
11/25/2003US6653336 Combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculation disorders
11/25/2003US6653334 Benzoxazole compound and pharmaceutical composition containing the same
11/25/2003US6653326 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof
11/25/2003US6653315 Substituted 5-amino-imidazolo-(4,3-e)-1,2,4-triazolo(1,5-c)-pyrimidines; central nervous system diseases; Parkinson's disease
11/25/2003US6653313 1,4-dihydropyridine compounds as bradykinin antagonists
11/25/2003US6653312 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
11/25/2003US6653310 For therapy of disease states mediated by the chemokine, Interleukin-8 (IL-8)
11/25/2003US6653308 Anticancer agents; antidiabetic agents; antiinflammatory agents
11/25/2003US6653306 Epoxy-steroidal aldosterone antagonist and angiotensin II antagonist combination therapy
11/25/2003US6653301 For therapy of cancer, diabetes and Alzheimer's disease
11/25/2003US6653300 Pyrazole compounds useful as protein kinase inhibitors
11/25/2003US6653299 Labelled factor XIIIa substrates
11/25/2003US6653283 Pharmaceutical compositions comprising troponin subunits, fragments and analogs thereof and methods of their use to inhibit angiogenesis
11/25/2003US6653116 Peptide for use in the treatment of inflammation, cancer, arteriosclerosis and psoriasis
11/25/2003US6652865 For decreasing the effect of intestinal metabolism on a drug
11/25/2003US6652856 Method for the treatment of fibrosis
11/25/2003CA2134679C Soluble analogs of probucol
11/25/2003CA2117305C Substituted imidazole derivatives and their preparation and use
11/20/2003WO2003095667A2 Autoimmune conditions and nadph oxidase defects
11/20/2003WO2003095613A2 Nucleic acids, polypeptides, and methods for modulating apoptosis
11/20/2003WO2003095498A1 Complex of organic medicines and beta-cyclodextrin derivatives and its preparing process
11/20/2003WO2003095471A2 Deoxycholic acid derivatives for the treatment of acute dysfunctions of portal and hepatic venous circulation
11/20/2003WO2003095457A1 Adenosine a3 receptor modulators
11/20/2003WO2003095452A1 Substituted pyrroline kinase inhibitors
11/20/2003WO2003095451A1 Carbamate-substituted pyrazolopyridines
11/20/2003WO2003095433A1 Hexahydro-pyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and preparation methods thereof
11/20/2003WO2003095432A1 Benzimidazole derivatives
11/20/2003WO2003095426A1 Novel enantiomers of tetrahydroisoquinoline derivatives and their pharmaceutically acceptable salts, their preparations and pharmaceutical compositions
11/20/2003WO2003095421A1 Amino acid analogues
11/20/2003WO2003095412A1 2-(α-HYDROXYPENTYL) BENZOATE AND ITS PREPARATION AND USE
11/20/2003WO2003095398A2 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same
11/20/2003WO2003094966A1 Arterialization agent and antiarterialization agent
11/20/2003WO2003094952A1 Intratumorally administered lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
11/20/2003WO2003094935A1 The use of the human urinary kininogenase in the manufacture of a medicine for treating and preventing cerebral embolism
11/20/2003WO2003094923A1 COMBINATION OF AN HMG-CoA REDUCTASE INHIBITOR AND A NITRATE ESTER
11/20/2003WO2003094917A1 Vintoperol-containing medicinal composition for transdermal administration
11/20/2003WO2003094915A1 Use of valsartan ot its metabolite to inhibit platelet aggregation
11/20/2003WO2003094914A1 Substantially pure solid form of the enol tautomer of 3-indolylpyruvic acid for use in the treatment of central nervous system disturbances
11/20/2003WO2003094910A1 Use of 8-prenylflavanones for anti-angiogenesis therapy and for fibrinolytic therapy
11/20/2003WO2003094904A1 Methods and compositions for the treatment of graft failure
11/20/2003WO2003094861A2 Bis-benzimidazoles and related compounds as potassium channel modulators
11/20/2003WO2003094859A2 Epha2 monoclonal antibodies and methods of use thereof
11/20/2003WO2003094856A2 1l1rl-1 as a cardiovascular disease marker and therapeutic target
11/20/2003WO2003094855A1 System and method for treating cardiac arrhythmias with fibroblast cells
11/20/2003WO2003094831A2 Novel diazabicyclic biaryl derivatives
11/20/2003WO2003094830A2 Novel azacyclic ethynyl derivatives
11/20/2003WO2003087062A3 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation
11/20/2003WO2003066023A9 A stable pharmaceutical formulation comprising torsemide modification ii
11/20/2003WO2003061696A3 Systems and methods for photodynamic therapy
11/20/2003WO2003055915A3 Human netrin receptor and uses thereof
11/20/2003WO2003054012A3 Leptin proteins
11/20/2003WO2003053352A3 Therapeutic compounds for treating dyslipidemic conditions
11/20/2003WO2003050504A3 Methods and compositions to treat cardiovascular disease usin g 1419, 58765 and 2201
11/20/2003WO2003048130A3 Peroxisome proliferator activated receptor agonists
11/20/2003WO2003044172A3 Composition comprising and method of using angiopoietin-like protein 3 angptl3
1 ... 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 ... 1595